Intuitive Surgical, Inc. $ISRG Shares Sold by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,021 shares of the medical equipment provider’s stock after selling 1,694 shares during the period. Foundations Investment Advisors LLC’s holdings in Intuitive Surgical were worth $578,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. lifted its holdings in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 50 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 2.9%

ISRG stock opened at $412.26 on Tuesday. The stock has a market capitalization of $146.01 billion, a P/E ratio of 49.97, a P/E/G ratio of 3.39 and a beta of 1.46. The firm has a 50-day simple moving average of $452.19 and a 200-day simple moving average of $504.81. Intuitive Surgical, Inc. has a 52 week low of $411.83 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.81 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Robert W. Baird boosted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. HSBC decreased their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group decreased their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. Nineteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $576.71.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 4,833 shares of company stock valued at $2,357,582. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.